🔎 Trials Near Me

Inicio › Cáncer (todos los tipos) › Utah

Ensayos clínicos de Cáncer (todos los tipos) en Utah

38 estudios sobre Cáncer (todos los tipos) buscan participantes en Utah.

Ciudades en Utah

Texto oficial del estudio (inglés)

Childhood Cancer Predisposition Study (CCPS)

  • Primary Children's Hospital, Salt Lake City
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 12 nov 2026 · NCT04511806

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Cedar Clinical Research Inc., Draper
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 10 nov 2026 · NCT07002034

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • University of Utah Sugarhouse Health Center, Salt Lake City
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
  • South Jordan Health Center, South Jordan
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06580314

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

  • START Mountain Region, LLC, West Valley City
ReclutandoFase 1
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07540572

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  • Utah Cancer Specialists Cancer Center - Medical Oncology, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06901531

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

  • Community Cancer Trials of Utah, Ogden
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07169851

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

  • Start Center for Cancer Research - Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT05856981

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • University of Utah - Huntsman Cancer Institute, Salt Lake City
  • Intermountain Healthcare - LDS Hospital, Salt Lake City
ReclutandoFase 2/3
Todas las edades · Todos los sexos · Actualizado el 2 nov 2026 · NCT03435796

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

  • START Mountain Region ( Site 1106), West Valley City
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07209111

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

  • Intermountain - Primary Children's Hospital ( Site 4014), Salt Lake City
ReclutandoFase 1/2
1 Month – 17 Years · Todos los sexos · Actualizado el 30 oct 2026 · NCT07630974

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  • Huntsman Cancer Institute /ID# 271618, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 oct 2026 · NCT06953960

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

  • University of Utah Huntsman Cancer Institute (HCI), Salt Lake City
  • University of Utah Primary Children's Hospital, Salt Lake City
Reclutando
Edades de 15 a 29 · Todos los sexos · Actualizado el 26 oct 2026 · NCT05958316

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

  • Huntsman Cancer Institute /ID# 272575, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06892522

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

  • START Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06880549

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT03328078

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

  • Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City
ReclutandoFase 1/2
1 Month – 17 Years · Todos los sexos · Actualizado el 6 oct 2026 · NCT06941272

SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care

  • Huntsman Cancer Institute/ University of Utah, Salt Lake City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07410689

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Cedar City Hospital, SW Cancer Clinic, Sandra Maxwell Cancer Center, Cedar City
  • Intermountain Healthcare, Salt Lake City
  • Dixie Regional Medical Center-River Road Campus, St. George
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT02693535

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • Huntsman Cancer Institute - University of Utah Health, Salt Lake City
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT04996875

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

  • Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT06634589

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • START Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06253871

Project: Every Child for Younger Patients With Cancer

  • Primary Children's Hospital, Salt Lake City
ReclutandoEstudio observacional
Hasta los 25 · Todos los sexos · Actualizado el 25 ago 2026 · NCT02402244

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

  • START Mountain Region, West Valley City
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT06678659

Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • University of Utah, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT05335928

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

  • Site 02, West Valley City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07276373

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
  • START Mountain Region, LLC., West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jul 2026 · NCT06657144

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • START Mountain Region, West Valley City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT05768139

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

  • GSK Investigational Site, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 jun 2026 · NCT06431594

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Reclutando
Edades de 18 a 75 · Todos los sexos · Actualizado el 17 jun 2026 · NCT05486572

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

  • GSK Investigational Site, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 may 2026 · NCT06551142

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 may 2026 · NCT01042379

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

  • START Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 may 2026 · NCT06132503

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 abr 2026 · NCT05297734

Improving Health Insurance Literacy Among Young Adult Cancer Survivors

  • Intermountain Health, Murray
  • University of Utah, Salt Lake City
Reclutando
Edades de 26 a 45 · Todos los sexos · Actualizado el 28 abr 2026 · NCT05829070

Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type

  • Huntsman Cancer Institute, Salt Lake City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 nov 2025 · NCT06484179

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Salt Lake City
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

  • Utah Cancer Specialists, Salt Lake City
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 may 2025 · NCT05234177

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Intermountain Medical Center, Murray
  • Huntsman Cancer Institute (The University of Utah), Salt Lake City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 nov 2024 · NCT03860883

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.